enGene Holdings Inc. financial data

Symbol
ENGN, ENGNW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
4868 Rue Levy, Suite 220, Saint Laurent, Quebec, Canada
State of incorporation
Canada (Federal Level)
Fiscal year end
October 31
Latest financial report
10-K - Q3 2024 - Dec 19, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.1K %
Debt-to-equity 16.9 %
Return On Equity -27.3 % -113%
Return On Assets -23.3 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 51M shares +120%
Common Stock, Shares, Outstanding 51M shares +120%
Entity Public Float 534M USD
Common Stock, Value, Issued 510M USD +96.6%
Weighted Average Number of Shares Outstanding, Basic 37.8M shares +5355%
Weighted Average Number of Shares Outstanding, Diluted 37.8M shares +5355%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 38.3M USD +133%
General and Administrative Expense 24M USD +150%
Operating Income (Loss) -62.3M USD -139%
Nonoperating Income (Expense) 7.14M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -55.2M USD +44.8%
Income Tax Expense (Benefit) -19K USD -212%
Net Income (Loss) Attributable to Parent -55.1M USD +44.8%
Earnings Per Share, Basic 1.46 USD/shares -99%
Earnings Per Share, Diluted 1.46 USD/shares -99%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 173M USD +112%
Marketable Securities, Current 65.3M USD
Assets, Current 247M USD +190%
Property, Plant and Equipment, Net 1.17M USD +98.5%
Operating Lease, Right-of-Use Asset 1.74M USD
Other Assets, Noncurrent 1.37M USD +47.7%
Assets 311M USD +258%
Accounts Payable, Current 1.41M USD +22.1%
Employee-related Liabilities, Current 3.48M USD +327%
Liabilities, Current 14.7M USD +179%
Operating Lease, Liability, Noncurrent 1.43M USD
Liabilities 38.6M USD +166%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.42M USD -39.7%
Retained Earnings (Accumulated Deficit) -255M USD -27.6%
Stockholders' Equity Attributable to Parent 273M USD +276%
Liabilities and Equity 311M USD +258%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -7.37M USD -18.4%
Net Cash Provided by (Used in) Financing Activities 12M USD
Net Cash Provided by (Used in) Investing Activities -506K USD -3792%
Common Stock, Shares, Issued 51M shares +120%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 4.13M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 81.5M USD +299%
Interest Paid, Excluding Capitalized Interest, Operating Activities 283K USD
Deferred Tax Assets, Valuation Allowance 49M USD +57.6%
Deferred Tax Assets, Gross 49.4M USD +58.8%
Operating Lease, Liability 1.85M USD
Depreciation 80K USD +73.9%
Payments to Acquire Property, Plant, and Equipment 506K USD +3792%
Lessee, Operating Lease, Liability, to be Paid 3.24M USD
Property, Plant and Equipment, Gross 2.78M USD +20%
Operating Lease, Liability, Current 423K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 464K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 452K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.39M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 323K USD
Deferred Tax Assets, Operating Loss Carryforwards 31.7M USD +67.4%
Preferred Stock, Shares Issued 0 shares
Lessee, Operating Lease, Liability, to be Paid, Year Four 299K USD
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 300K USD +50%
Share-based Payment Arrangement, Expense 5.32M USD +54.3%
Interest Expense 728K USD -38.1%